{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:01:48Z","timestamp":1790740908875,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102984","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:28:16Z","timestamp":1787261296000},"page":"102984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Superior in-vivo efficacy of integrated tumor neoantigen vaccination with adoptive neoantigen-reactive T-cell therapy in solid tumor"],"prefix":"10.1016","volume":"72","author":[{"given":"Guozheng","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5569-4261","authenticated-orcid":false,"given":"Boyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-5764","authenticated-orcid":false,"given":"Qingzhao","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runsheng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102984_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.tranon.2026.102984_bib0002","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15537\/1658-3175.8333","article-title":"Global cancer burden growing, amidst mounting need for services","volume":"45","year":"2024","journal-title":"Saudi Med. J."},{"issue":"4","key":"10.1016\/j.tranon.2026.102984_bib0003","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijrobp.2022.02.023","article-title":"Local consolidative therapy versus systemic therapy alone for metastatic non-small cell lung cancer: a systematic review and meta-analysis","volume":"114","author":"Wu","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0004","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","article-title":"Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"10","key":"10.1016\/j.tranon.2026.102984_bib0005","article-title":"Targeted therapies in the most common advanced solid tumors, drug resistance, and counteracting progressive micrometastatic disease: the next frontier of research","volume":"6","author":"Nicolini","year":"2025","journal-title":"MedComm (2020)"},{"issue":"13","key":"10.1016\/j.tranon.2026.102984_bib0006","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1158\/1078-0432.CCR-14-1213","article-title":"Intratumoral heterogeneity: from diversity comes resistance","volume":"21","author":"Pribluda","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102984_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9773-2_1","article-title":"Status of immune oncology: challenges and opportunities","volume":"2055","author":"Cesano","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"26","key":"10.1016\/j.tranon.2026.102984_bib0008","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.tranon.2026.102984_bib0009","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6230","key":"10.1016\/j.tranon.2026.102984_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.tranon.2026.102984_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","article-title":"Genomic and transcriptomic features of response to Anti-PD-1 therapy in metastatic melanoma","volume":"168","author":"Hugo","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.102984_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"8","key":"10.1016\/j.tranon.2026.102984_bib0013","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102984_bib0014","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"7953","key":"10.1016\/j.tranon.2026.102984_bib0016","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-023-05787-1","article-title":"Neoantigen-targeted CD8(+) T cell responses with PD-1 blockade therapy","volume":"615","author":"Puig-Saus","year":"2023","journal-title":"Nature"},{"issue":"6583","key":"10.1016\/j.tranon.2026.102984_bib0017","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"issue":"8056","key":"10.1016\/j.tranon.2026.102984_bib0018","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.tranon.2026.102984_bib0019","article-title":"Melanoma vaccines: comparing novel adjuvant treatments in high-risk patients","volume":"13","author":"Broderick","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.tranon.2026.102984_bib0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102984_bib0021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","article-title":"Genetic and non-genetic clonal diversity in cancer evolution","volume":"21","author":"Black","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.tranon.2026.102984_bib0022","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/2159-8290.CD-23-1334","article-title":"Lifileucel, an autologous tumor-infiltrating lymphocyte monotherapy, in patients with advanced non-small cell lung cancer resistant to immune checkpoint inhibitors","volume":"14","author":"Schoenfeld","year":"2024","journal-title":"Cancer Discov."},{"issue":"5594","key":"10.1016\/j.tranon.2026.102984_bib0023","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"issue":"6184","key":"10.1016\/j.tranon.2026.102984_bib0024","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41467-024-55420-6","article-title":"Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies","volume":"16","author":"Kuilman","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.tranon.2026.102984_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000848","article-title":"Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up","volume":"8","author":"van den Berg","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.tranon.2026.102984_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001743","article-title":"Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy","volume":"9","author":"Nissani","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.102984_bib0028","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1158\/2326-6066.CIR-15-0106","article-title":"Special conference on tumor immunology and immunotherapy: a new chapter","volume":"3","author":"Byrne","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"7870","key":"10.1016\/j.tranon.2026.102984_bib0029","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.tranon.2026.102984_bib0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.102984_bib0031","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41571-022-00607-3","article-title":"Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion","volume":"19","author":"Amini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6230","key":"10.1016\/j.tranon.2026.102984_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.tranon.2026.102984_bib0033","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"issue":"6127","key":"10.1016\/j.tranon.2026.102984_bib0034","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"issue":"7457","key":"10.1016\/j.tranon.2026.102984_bib0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.tranon.2026.102984_bib0036","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102984_bib0037","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1007\/s00432-023-04683-5","article-title":"Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer","volume":"149","author":"Qin","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.tranon.2026.102984_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202202168","article-title":"Two-pronged intracellular Co-delivery of antigen and adjuvant for synergistic cancer immunotherapy","volume":"34","author":"Meng","year":"2022","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.tranon.2026.102984_bib0039","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6071","article-title":"A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer","volume":"6","author":"Ni","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/02656736.2022.2032406","article-title":"Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6","volume":"39","author":"Huang","year":"2022","journal-title":"Int. J. Hyperthermia"},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0041","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41467-023-40886-7","article-title":"Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0042","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"32","key":"10.1016\/j.tranon.2026.102984_bib0043","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","article-title":"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens","volume":"26","author":"Dudley","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102984_bib0044","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s12272-016-0820-y","article-title":"Diverse macrophages polarization in tumor microenvironment","volume":"39","author":"Rhee","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.tranon.2026.102984_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642285","article-title":"Mechanisms of macrophage plasticity in the tumor environment: manipulating activation State to improve outcomes","volume":"12","author":"Ricketts","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102984_bib0046","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.tranon.2026.102984_bib0047","doi-asserted-by":"crossref","first-page":"262","DOI":"10.21037\/atm.2016.06.17","article-title":"Neoantigen-based cancer immunotherapy","volume":"4","author":"Bobisse","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.tranon.2026.102984_bib0048","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.bmc.2017.10.021","article-title":"Personalized neoantigen vaccines: a new approach to cancer immunotherapy","volume":"26","author":"Aldous","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0049","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","article-title":"Overcoming tgf\u03b2-mediated immune evasion in cancer","volume":"22","author":"Tauriello","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102984_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","article-title":"Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy","volume":"16","author":"Cai","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102984_bib0051","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2020.09.038","article-title":"Personalized cancer vaccines: clinical landscape, challenges, and opportunities","volume":"29","author":"Shemesh","year":"2021","journal-title":"Mol. Ther."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:40:09Z","timestamp":1790739609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S1936523326003207"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102984","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superior in-vivo efficacy of integrated tumor neoantigen vaccination with adoptive neoantigen-reactive T-cell therapy in solid tumor","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102984"}}